1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with tryptophan in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (tryptophan) | Trials (tryptophan) | Recent Studies (post-2010) (tryptophan) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 32,762 | 936 | 7,183 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | tryptophan (IC50) |
---|---|---|---|
Myeloperoxidase | Homo sapiens (human) | 2.25 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Lash, GE; Liu, Y; Qian, Y; Shi, K; Su, Y; Wang, Q; Xuan, X | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and tryptophan
Article | Year |
---|---|
Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; Female; Humans; Indoles; Metabolome; Metabolomics; Middle Aged; Neoplasm Invasiveness; Phenylalanine; Platelet Activating Factor; Tryptophan; Tumor Necrosis Factor-alpha | 2018 |